🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Harriette Van Spall, MD MPH 🇨🇦 Francesco Paneni Ekaterini Lambrinou💙 Henry Han Biljana Parapid, MD, PhD, FESC Giuseppe Galati Vass Vassiliou Mamas A. Mamas Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Silvia Castelletti Dr Anastasia Mihailidou FAHA FCSANZ FESC #DANCANVAS brilliantly dissected by Harriette Van Spall, MD MPH 🇨🇦 shocking a CV prevention trial enrolling within the last decade and funded by Danish Research Council was supported without including women

In this study of patients undergoing #TAVI, significant left ventricular outflow tract calcification was associated with worse short-term clinical and functional outcomes and higher 1-year death compared to patients without LVOT calcification. #EIJBestOf eurointervention.pcronline.com/article/impact…

Complex MR treaded using the Highlife TMVR prosthesis! Excellent case presentation by Niklas Schofer at the #HamburgInterventions 2022!

@MoritzSeiffert Nils Soerensen Benedikt Schrage Benedikt Koell Daniel Kalbacher @larawald Christoph Waldeyer @FabianJBrunner Niklas Schofer Where is revascularisation in HF patients heading ?

Rethink the #complementsystem in nephrology and enjoy beautiful Hamburg! Join the Freiwald lab at the University Center Hamburg-Eppendorf HCKH_Hamburg UKE Hamburg. BMBF-funded positions for PhD, Post-doc and Technician. Get in touch at freiwaldlab.com.

Hot off the press. Our work on „Validation of a 0/1 h Algorithm for Rapid Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I Assay“ is published @Clin_Chem_AACC #BACC #ClinChem #biomarkers @johannesneuman Betül Toprak, MD Raphael Twerenbold, MD track.smtpsendmail.com/9032119/c?p=Qs…

In this new Journal column, the authors take different sides to debate the future of transcatheter mitral valve replacement and whether it will remain a niche therapy or evolve into another breakthrough technology in interventional cardiology. eurointervention.pcronline.com/article/transc…

New study by Jonas Lehmacher & others evaluated 0/1h algorithm using troponin that allowed triage of patients with suspected myocardial infarction (MI) and proves strong prognostic value for death and MI up to three years. #LabMedTwitter #CardioTwitter 👇 buff.ly/3M7td9k

Original Article: Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality nej.md/3sssHwq #ESCCongress

The investigator-initiated DEDICATE trial will randomly explore the efficacy and safety of transcatheter aortic valve implantation compared to surgical aortic valve replacement in low-to-intermediate-risk patients aged 65 years or older. ow.ly/1N3T50PH6Ue

Heute ist #Weltherztag unter dem Motto „Schütze Deine Gefäße! Informiere Dich!". Gut ein Drittel aller weltweiten Todesfälle geht auf kardiovaskuläre Erkrankungen zurück. Priv.-Doz. Dr. Christina Magnussen aus dem #UKEHamburg im Video: uke.de/videos Deutsche Herzstiftung

Editorial: Another Early Win for TAVI in Low-Risk Patients nej.md/3J5F7j5

Original Article: Transcatheter or Surgical Treatment of Aortic-Valve Stenosis (DEDICATE-DZHK6) nej.md/3TLx8MT Editorial: Another Early Win for TAVI in Low-Risk Patients nej.md/3J5F7j5 American College of Cardiology #ACC24

In 32,000 AF pts from COMBINE-AF, cardiac #biomarkers sign.⤴️ #heartfailure risk prediction! hs-cTnT as important as NTproBNP pointing to a promising dual-marker strategy. Results simultaneously published in JACC Journals @PaulMHaller Robert Giugliano #ESCCongress

Can biomarkers improve HF risk assessment in AF patients? Superb analysis by @PaulMHaller simultaneously published in JACC, shows hs-cTnT is as important as NTproBNP, with significant but lesser contribution from GDF-15. #COMBINE-AF